The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines
Condit, Richard C.
Robertson, James S.
Fast, Patricia E.
Smith, Emily R.
Chen, Robert T
For the Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)
MetadataShow full item record
Summary in foreign language
Several protein vaccine candidates are among the COVID-19 vaccines in development. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) has prepared a standardized template to describe the key considerations for the benefit-risk assessment of protein vaccines. This will help key stakeholders to assess potential safety issues and understand the benefit-risk of such a vaccine platform. The structured and standardized assessment provided by the template would also help contribute to improved public acceptance and communication of licensed protein vaccines.
Estadísticas Google Analytics
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.